33.09MMarket Cap-1352P/E (TTM)
3.001High2.520Low64.65KVolume2.920Open2.890Pre Close181.34KTurnover1.54%Turnover RatioLossP/E (Static)11.82MShares5.00052wk High5.13P/B11.76MFloat Cap1.80052wk Low--Dividend TTM4.20MShs Float5.000Historical High--Div YieldTTM16.64%Amplitude1.800Historical Low2.805Avg Price1Lot Size
Medicus Pharma Stock Forum
📊⚡️📊
Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region
Monday, 2nd December at 7:30 am
TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (TSXV: MDCX) ("Medicus" or the "Company") is pleased to announce an agreement with Swanielle Inc. ("Swanielle") to explore expansion of Phase 2 clinical study for treatment of Basal Cell Carcinoma (BCC) in the Asia-pacific region
.
Under the agreemen...
📊⚡️📊
📊⚡️📊
Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States
No comment yet